StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) stock

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Earnings

Longeveron's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q3 FY2026
$100.00K
EPS, Q3 FY2026
-$1.91
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Longeveron's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026after the close$100.00K–-$1.91Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 13, 2026after the close$398.00K-0.5%-$0.19Release
Q3 FY2025ended Sep 30, 2025Nov 4, 2025after the close–––Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025after the close–––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$400.00K–-$0.34Release
Q4 FY2024ended Dec 31, 2024Feb 28, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$773.00K–-$0.34Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024after the close–––Release
Q1 FY2023ended Mar 31, 2023May 12, 2023before the open$300.00K-25.0%-$0.22Release
Q4 FY2022ended Dec 31, 2022Mar 10, 2023during market hours$100.00K-50.0%-$0.21Release
Q2 FY2022ended Jun 30, 2022Aug 12, 2022before the open$500.00K–-$0.27Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Longeveron has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Longeveron puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Longeveron filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. News
  3. News
  4. Update
  5. Results
  6. Results
  7. News
  8. News
  9. News
  10. Results
  11. Results
  12. News
  13. News
  14. News
  15. Results

See a number that looks wrong?